First Izokibep Publication

News

May 16, 2023

Solna, Sweden, May 16, 2023. The first publication outlining the pre-clinical development and first-in-human study of izokibep is now available online.

The article, Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis, is published in mAbs, Volume 15, Issue 1 (2023). mAbs is a well renowned multidisciplinary, open access journal dedicated to the art and science of antibody research and development.

Citation and link to publication
Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter, Karin Dillner Bergstedt, Elin Gunneriusson, Ingmarie Höidén Guthenberg, Anders Wennborg, Andrew C. Nyborg, Amol P. Kamboj, Paul M. Peloso, David Bejker & Fredrik Y. Frejd (2023) Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis, mAbs, 15:1, DOI: 10.1080/19420862.2023.2209920.

https://www.tandfonline.com/doi/full/10.1080/19420862.2023.2209920